Inogen Inc (INGN)
7.06
+0.16
(+2.32%)
USD |
NASDAQ |
Apr 24, 16:00
7.06
0.00 (0.00%)
After-Hours: 20:00
Inogen Research and Development Expense (Quarterly): 6.714M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.714M |
| September 30, 2023 | 4.489M |
| June 30, 2023 | 4.293M |
| March 31, 2023 | 5.344M |
| December 31, 2022 | 5.934M |
| September 30, 2022 | 4.581M |
| June 30, 2022 | 6.064M |
| March 31, 2022 | 5.364M |
| December 31, 2021 | 4.684M |
| September 30, 2021 | 3.754M |
| June 30, 2021 | 4.123M |
| March 31, 2021 | 4.015M |
| December 31, 2020 | 3.674M |
| September 30, 2020 | 3.511M |
| June 30, 2020 | 3.29M |
| March 31, 2020 | 3.605M |
| December 31, 2019 | 3.628M |
| September 30, 2019 | 2.636M |
| June 30, 2019 | 1.468M |
| March 31, 2019 | 1.669M |
| December 31, 2018 | 1.742M |
| September 30, 2018 | 2.096M |
| June 30, 2018 | 1.775M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.416M |
| December 31, 2017 | 1.369M |
| September 30, 2017 | 1.375M |
| June 30, 2017 | 1.26M |
| March 31, 2017 | 1.309M |
| December 31, 2016 | 1.216M |
| September 30, 2016 | 1.35M |
| June 30, 2016 | 1.379M |
| March 31, 2016 | 1.168M |
| December 31, 2015 | 1.226M |
| September 30, 2015 | 1.116M |
| June 30, 2015 | 0.975M |
| March 31, 2015 | 0.863M |
| December 31, 2014 | 0.665M |
| September 30, 2014 | 0.798M |
| June 30, 2014 | 0.879M |
| March 31, 2014 | 0.635M |
| December 31, 2013 | 0.581M |
| September 30, 2013 | 0.674M |
| June 30, 2013 | 0.64M |
| March 31, 2013 | 0.503M |
| December 31, 2012 | 0.531M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.468M
Minimum
Jun 2019
6.714M
Maximum
Dec 2023
4.272M
Average
4.123M
Median
Jun 2021
Research and Development Expense (Quarterly) Benchmarks
| Oragenics Inc | 11.04M |
| Palatin Technologies Inc | 5.554M |
| Oramed Pharmaceuticals Inc | 1.766M |
| vTv Therapeutics Inc | 2.138M |
| G1 Therapeutics Inc | 7.38M |